Glycimark M 80 mg Tablet 15 Tablets
Rs. 121.88
Title
Glycimark M 80 mg Tablet 15 Tablets
Prescription drug
Composition
: Likely Glimepiride plus Metformin (fixed‑dose combination; verify exact strengths from pack before final listing)
About:
Glycimark M 80 mg Tablet is an oral antidiabetic combination used to manage type 2 diabetes mellitus when diet, exercise and single‑agent therapy are inadequate. It typically combines a sulfonylurea with metformin to help control blood glucose levels throughout the day.
Usage Instructions Take the tablet with meals as advised by your physician to reduce stomach upset and risk of low sugar. Do not skip meals after taking the dose and follow the dosing schedule regularly.
Benefits Helps control fasting and post‑prandial blood glucose, lowering the risk of complications like neuropathy, nephropathy and retinopathy when used long term. Combination therapy can be more effective than single‑agent therapy in patients with higher glucose levels.
How it Works The sulfonylurea component stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin sensitivity. This complementary action allows better utilisation of glucose by body tissues.
Side Effects May cause hypoglycaemia, gastrointestinal upset (nausea, diarrhoea, abdominal pain), headache or metallic taste. Serious but rare effects include lactic acidosis and severe allergic reactions; seek immediate care if such symptoms occur.
Safety Advice Not suitable for type 1 diabetes, severe kidney or liver disease or diabetic ketoacidosis. Regular blood glucose and renal function monitoring is advised; avoid alcohol excess and follow dietary advice.
Storage Store in a cool, dry place at room temperature in the original pack. Keep away from children and pets.
Usage Instructions Take the tablet with meals as advised by your physician to reduce stomach upset and risk of low sugar. Do not skip meals after taking the dose and follow the dosing schedule regularly.
Benefits Helps control fasting and post‑prandial blood glucose, lowering the risk of complications like neuropathy, nephropathy and retinopathy when used long term. Combination therapy can be more effective than single‑agent therapy in patients with higher glucose levels.
How it Works The sulfonylurea component stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin sensitivity. This complementary action allows better utilisation of glucose by body tissues.
Side Effects May cause hypoglycaemia, gastrointestinal upset (nausea, diarrhoea, abdominal pain), headache or metallic taste. Serious but rare effects include lactic acidosis and severe allergic reactions; seek immediate care if such symptoms occur.
Safety Advice Not suitable for type 1 diabetes, severe kidney or liver disease or diabetic ketoacidosis. Regular blood glucose and renal function monitoring is advised; avoid alcohol excess and follow dietary advice.
Storage Store in a cool, dry place at room temperature in the original pack. Keep away from children and pets.
₹121.88
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About:
Glycimark M 80 mg Tablet is an oral antidiabetic combination used to manage type 2 diabetes mellitus when diet, exercise and single‑agent therapy are inadequate. It typically combines a sulfonylurea with metformin to help control blood glucose levels throughout the day.
Usage Instructions Take the tablet with meals as advised by your physician to reduce stomach upset and risk of low sugar. Do not skip meals after taking the dose and follow the dosing schedule regularly.
Benefits Helps control fasting and post‑prandial blood glucose, lowering the risk of complications like neuropathy, nephropathy and retinopathy when used long term. Combination therapy can be more effective than single‑agent therapy in patients with higher glucose levels.
How it Works The sulfonylurea component stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin sensitivity. This complementary action allows better utilisation of glucose by body tissues.
Side Effects May cause hypoglycaemia, gastrointestinal upset (nausea, diarrhoea, abdominal pain), headache or metallic taste. Serious but rare effects include lactic acidosis and severe allergic reactions; seek immediate care if such symptoms occur.
Safety Advice Not suitable for type 1 diabetes, severe kidney or liver disease or diabetic ketoacidosis. Regular blood glucose and renal function monitoring is advised; avoid alcohol excess and follow dietary advice.
Storage Store in a cool, dry place at room temperature in the original pack. Keep away from children and pets.
Usage Instructions Take the tablet with meals as advised by your physician to reduce stomach upset and risk of low sugar. Do not skip meals after taking the dose and follow the dosing schedule regularly.
Benefits Helps control fasting and post‑prandial blood glucose, lowering the risk of complications like neuropathy, nephropathy and retinopathy when used long term. Combination therapy can be more effective than single‑agent therapy in patients with higher glucose levels.
How it Works The sulfonylurea component stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin sensitivity. This complementary action allows better utilisation of glucose by body tissues.
Side Effects May cause hypoglycaemia, gastrointestinal upset (nausea, diarrhoea, abdominal pain), headache or metallic taste. Serious but rare effects include lactic acidosis and severe allergic reactions; seek immediate care if such symptoms occur.
Safety Advice Not suitable for type 1 diabetes, severe kidney or liver disease or diabetic ketoacidosis. Regular blood glucose and renal function monitoring is advised; avoid alcohol excess and follow dietary advice.
Storage Store in a cool, dry place at room temperature in the original pack. Keep away from children and pets.